Webinar date: Friday, June 26, 2020 12:00pm EDT
This webinar was sponsored by the Assembly on Respiratory Cell and Molecular Biology (RCMB) Innovation and Entrepreneurial Working Group.
Presenters:
Louise Hecker, PhD, Associate Professor, University of Arizona, Founder and Chief Scientific Officer (CSO) of Fibronox
Naftali Kaminski, MD, Boehringer-Ingelheim Endowed Professor of Internal Medicine
Chief of Pulmonary, Critical Care and Sleep Medicine Department of Medicine, Yale School of Medicine
Erica Park, PharmD, Senior Director, Clinical Development, and Monica Sandberg, PhD, Head of Regulatory Affairs, Pliant Therapeutics, San Francisco, CA
Panelists:
Tim Watkins, MD MSc, Executive Director, Clinical Research, Respiratory Disease Area Lead Inflammation Therapeutics, Gilead Sciences Inc
Toby Maher, MD/PhD, Professor of Medicine and Director of Interstitial Lung Disease, Keck School of Medicine, University of Southern California, Los Angeles, USA
Colin Reisner, MD, Head, Respiratory Global Medicine, AstraZeneca; CEO, Pearl Therapeutics, Inc
David Morris, MD, Operating Partner, Novartis Venture Fund and Chief Medical Officer of Enterprise Therapeutics
Alan H Cohen, MD, Vice President of Global Medical Affairs, Eidos Therapeutics, San Francisco, CA
Moderator:
Milica Vukmirovic, PhD, Michael DeGroote Innovation, Commercialization, and Entrepreneurship Fellow, McMaster University; Innovation and Commercialization Consultant, St. Joseph’s Research Institute
